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Apoptosis is increasingly recognized as a major mode of cell
demise after ischemic injury to the kidney. The mediators of
apoptotic cell death are many and include changes in intra-
cellular pH, calcium, free radicals, ceramide, and adenosine
triphosphate (ATP) depletion. Recently, we identified guano-
sine triphosphate (GTP) depletion as an independent trigger
for apoptotic death after chemical anoxia in vitro. We further
demonstrated that GTP salvage with guanosine inhibits tubu-
lar cell apoptosis after ischemic injury in vivo. This inhibition
of apoptosis was accompanied by a significant protective effect
on renal function. We also showed that p53 is the mediator of
apoptosis in the setting of GTP depletion and ischemic injury.
Indeed, salvage of GTP with guanosine prevented the ischemia-
induced increase in p53 protein. Further, pifithrin-alpha, a
potent and specific inhibitor of p53, inhibited apoptosis and
protected renal function with a profile similar to that seen with
guanosine. Finally, the protective effects of pifithrin-alpha in-
volved both down-regulation of the transcriptional activation
of Bax and a direct inhibition of p53 translocation to mito-
chondria. We propose that GTP depletion and activation of
p53 are major inducers of apoptotic cell death after ischemic
renal injury. In this setting, guanosine and pifithrin-alpha are
potent inhibitors of apoptosis and are thus potentially useful in
preventing and ameliorating functional injury to the ischemic
kidney.
Ischemic renal injury has been traditionally associated
with tubular cell necrosis along with obstructive cast for-
mation, disruption of architecture, and a significant in-
flammatory response. Early attempts at preventing and
treating ischemic injury were primarily targeted at this
“necrotic” phenotype and generally met with moder-
ate success, at least in animal models of this disease.
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Only recently did apoptosis emerge as a significant mode
of cell death during ischemic renal injury [1, 2]. While
the contribution of apoptotic cell death to functional
deterioration of the organ is obvious in conditions like
myocardial infarction and stroke, it is less clear how
apoptotic dropout of tubular cells can impact glomeru-
lar filtration rate (GFR). Nevertheless, recent reports
have demonstrated that interference with the apoptotic
program does translate into a protective effect on renal
function [3–5]. This opened new avenues for poten-
tial therapeutic modalities targeting various steps of the
highly organized and fairly well-understood process of
apoptotic cell demise.
THE MEDIATORS OF CELL DEATH DURING
ISCHEMIC RENAL INJURY
The apoptotic program itself has been extensively char-
acterized and is fairly well preserved among cell types,
tissues, and species. However, the primary triggers of this
program are many and do show organ, species, and in-
sult specificities. In particular, ischemia/reperfusion (I/R)
injury is accompanied by a myriad of changes in sig-
naling molecules and metabolic effectors that can, in-
dependently or in concert, trigger cell death in vari-
ous forms. These include changes in intracellular pH,
calcium, ceramide, free radicals, hypoxia and adenosine
triphosphate (ATP) depletion. While all of these factors
are grossly deranged during abrupt necrotic cell death,
they can also be specific effectors of apoptotic death un-
der certain circumstances. The current literature suggests
that the mode of cell death that results from ischemic
injury depends in part on the severity of the primary
alterations in these factors. For example, severe ATP
depletion invariably causes necrosis that is likely related
to cessation of all vital enzymatic functions and Na/K
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ATPase shutdown. Conversely, milder ATP depletion,
when sustained, can specifically trigger the apoptotic
cascade. Thus, necrosis and apoptosis appear to be part of
a spectrum of cells death profiles and they often coexist,
reflecting the differential severity of the insult in various
parts of the tissue.
GUANOSINE TRIPHOSPHATE (GTP)
DEPLETION AS AN IMPORTANT POTENTIAL
TRIGGER FOR APOPTOSIS
Guanine nucleotides are favorite targets to induce
apoptosis in activated lymphocytes and malignant cells.
Thus, the importance of targeting and inhibiting the GTP
synthetic pathway is supported by abundant data in the
immunobiology and cancer literature [6]. This “privi-
leged” status of guanine nucleotides is based on the very
small size of GTP pools compared to ATP. Indeed, in
most cells, ATP and GTP are in equilibrium with a ra-
tio of about 7 to 1. This makes GTP significantly more
rate-limiting for nucleic acid synthesis under conditions
of nucleotide depletion. For example, a 50% reduction
in both ATP and GTP translates into a more significant
depletion in the absolute amount of GTP as compared to
ATP. In addition, the GTP/GDP ratio is an important reg-
ulator of the function of a variety of signaling GTPases.
These molecules cycle between active GTP-bound and
inactive GDP-bound states. This cycle is normally con-
trolled by a myriad of regulating proteins such as GEFs,
GAPs, and GDIs. However, the ambient GTP/GDP ra-
tio has also been shown to affect the GTPase cycle and
can thus impact the function of these proteins. GTPases
such as members of the Ras and Rho families are impor-
tant regulators of cell proliferation and apoptosis. There-
fore, GTP depletion can modulate cell death through
these signaling molecules beyond its effect on nucleic acid
synthesis.
IS GTP DEPLETED DURING ISCHEMIC INJURY?
ATP depletion is the primary result of inhibition of
the respiratory chain during states of hypoxia, chemi-
cal anoxia, and ischemia. However, the ATP and GTP
pools are tightly linked at various biochemical steps. The
enzyme nucleotide diphosphate kinase catalyzes the re-
action ATP + guanosine diphosphate (GDP) = adeno-
sine diphosphate (ADP) + GTP. This keeps most ATP
and GTP pools under strict equilibrium. Furthermore,
ATP is a cofactor for the enzyme GTP synthetase while
GTP is a cofactor for both adenosine monophosphate
(AMP) deaminase and adenylosuccinate synthetase. Fi-
nally, GDP is an important regulator of the citric acid
cycle. These biochemical facts predict that ATP and GTP
pools should vary in parallel under most physiologic and
pathophysiologic conditions. Indeed, we recently demon-
strated that both chemical anoxia in vitro and renal is-
chemia in vivo are states of combined ATP and GTP de-
pletion [7]. This suggested that GTP depletion could be
an important and independent modulator of cell death
phenotype under these conditions.
MODELS OF SELECTIVE NUCLEOTIDE
DEPLETION POINT TO GTP DEPLETION AS
THE PRIMARY INDUCER OF APOPTOSIS
Using potent and specific inhibitors of GTP and ATP
synthesis like mycophenolic acid and alanosine, along
with specific substrate-controlled media, we were able to
develop models of sustained and selective ATP or GTP
depletion in cell culture. These models linked the apop-
totic phenotype specifically to the depletion of GTP. Fur-
thermore, these models showed that ATP depletion, if
unaccompanied by GTP depletion, results primarily in
necrosis [7]. These models suggested that during states of
generalized nucleotide depletion as occurs with ischemic
renal injury, the reduction in GTP could be the primary
culprit in triggering apoptosis. Therefore, we hypothe-
sized that manipulating GTP pools during or after an is-
chemic insult might alter the apoptotic response observed
under these conditions.
GTP SALVAGE WITH GUANOSINE AFTER
ISCHEMIC INJURY INHIBITS TUBULAR CELL
APOPTOSIS AND PROTECTS FUNCTION
In a model of bilateral renal artery clamp in the mouse
and rat, we recently showed that intraperitoneal admin-
istration of guanosine normalized the GTP pools as early
as 1 hour into the reperfusion phase [8]. ATP pools were
not significantly increased. This selective and early re-
pletion of GTP was accompanied by a major reduction
in the number of apoptotic cells in all medullary tubular
segments observed at 24 hours after reperfusion. More
important, the repletion of GTP and inhibition of apop-
tosis did not alter the overall amount of tubular necrosis.
Nevertheless, there was a dramatic improvement in re-
nal function that was sustained even when examined at
72 hours after the insult. These results underscored the
importance of GTP as a modulator of apoptosis during is-
chemic injury. They further pointed to apoptosis of tubu-
lar cells as a significant factor in the functional outcome of
ischemic renal injury, independent of necrotic cell death.
Other effects of guanosine unrelated to GTP repletion
could not be excluded in these studies.
p53 AS THE MEDIATOR OF GTP
DEPLETION-INDUCED APOPTOSIS AFTER
ISCHEMIC RENAL INJURY
p53 is the master regulator of cell cycle and apopto-
sis. It functions to induce cell cycle arrest or apoptosis
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in response to DNA damage. It is activated by a variety
of stimuli, including irradiation, hypoxia, and nucleotide
depletion. It is the most frequently mutated gene in can-
cer and loss of p53 function correlates with the resistance
of neoplasms to chemotherapy and radiation-induced
apoptosis. A role for p53 in ischemia-induced apopto-
sis is well accepted in strokes but not in cardiac or re-
nal ischemia [9]. A recent report suggested that down-
regulation of inosine-5′-monophosphate dehydrogenase
(IMPDH), the rate-limiting enzyme in GTP synthesis, is
a requirement for the biologic activity of p53 [10]. There-
fore, we hypothesized that GTP depletion-induced apop-
tosis during ischemic renal injury might be mediated by
p53 [11].
We first examined the effect of ischemia on p53 and
documented a significant increase in the protein lev-
els, primarily in the renal medulla. We also showed
that guanosine, which potently inhibits ischemia-induced
tubular apoptosis, prevents this increase in p53. This
suggested that p53 is the mediator of GTP depletion-
induced apoptosis. Furthermore, pifithrin-alpha, a potent
and specific inhibitor of p53, reproduced the protective
profile seen with guanosine. That is, it inhibited apopto-
sis and protected function without significantly altering
the necrotic damage postischemia. However, and unlike
guanosine, pifithrin-alpha was protective when given up
to 14 hours after the ischemic insult. This correlated well
with the time course of p53 increase that occurs after
ischemia.
PIFITHRIN-ALPHA DOWN-REGULATES THE
TRANSCRIPTIONAL ACTIVATION OF BAX
AND INHIBITS THE TRANSLOCATION
OF p53 TO MITOCHONDRIA
p53 induces apoptosis primarily by activating proapop-
totic proteins like Bax and Noxa that trigger programmed
cell death via the intrinsic pathway. Indeed, the antiapop-
totic effects of pifithrin-alpha after ischemia could be in
part ascribed to a significant reduction in Bax protein.
However, Bax was highly expressed in control tissues and
its increase after ischemia was modest. We, therefore,
examined alternative mechanisms by which the inhibi-
tion of p53 prevents apoptosis. One such mechanism was
the recent demonstration of hypoxia-induced apoptosis
by translocation of p53 to mitochondria in cell culture
[12]. This translocation was sufficient to induce apoptosis
and was transcription-independent. Using immunofluo-
rescence labeling, we showed a significant p53 signal in
ischemic kidneys that strongly localized to mitochondria.
This mitochondrial p53 signal was inhibited by pifithrin-
alpha, suggesting that migration of p53 to mitochondria
is involved in the ischemic apoptotic response.
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Fig. 1. Guanosine triphosphate (GTP) depletion and p53 in ischemia-
induced apoptosis. This model proposes that GTP depletion and the
activation of p53 are sequential steps underlying the apoptotic pheno-
type seen after renal ischemia. Guanosine and pifithrin-alpha restore
GTP and inhibit p53, respectively, thus preventing apoptosis.
CONCLUSION
Our studies suggest that GTP depletion and the acti-
vation of p53 are sequential steps in ischemia-induced
apoptosis. Inhibiting this pathway with guanosine or
pifithrin-alpha significantly reduces tubular cell apoptosis
and prevents the deterioration in renal function (Fig. 1).
These studies also underscore the importance of apop-
totic cell death in impacting renal function after ischemia.
Apoptosis-based therapies should therefore be a focus of
future investigation aimed at reducing the mortality and
morbidity of ischemic renal injury.
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Cell cyle regulation: Repair and regeneration in acute renal fail-
ure. Research into mechanisms of acute renal failure has begun
to reveal molecular targets for possible therapeutic interven-
tion. Much useful knowledge into the causes and prevention
of this syndrome has been gained by the study of animal mod-
els. Most recently, investigation of the effects on acute renal
failure of selected gene knock-outs in mice has contributed to
our recognition of many previously unappreciated molecular
pathways. Particularly, experiments have revealed the protec-
tive nature of two highly induced genes whose functions are to
inhibit and control the cell cycle after acute renal failure. By
use of these models we have started to understand the role of
increased cell cycle activity after renal stress, and the role of
proteins induced by these stresses that limit this proliferation.
The consequences of nephrotoxic renal injury include
segment-specific changes in cell viability and reduced
renal function. In experimental models necrosis of the
S3 segment of the proximal tubule predominates and
apoptosis occurs in a minority of cells, especially those
of the distal nephron. Functionally, severe vasoconstric-
tion, principally applied to the afferent arteriole, reduced
glomerular filtration rate (GFR), and loss of autoregula-
tory responses characterize the renal microvascular re-
sponse to injury. The kidney is also unable to generate
maximum urinary concentration or to reclaim filtered
sodium fully. Reversal of these changes coincides with
Key words: cyclin-dependent kinase, cell cycle, cyclin kinase inhibitors,
p21.
the reestablishment of the normal renal epithelial bar-
rier with new cells that reline the denuded tubules.
The process of regeneration and recovery begins
shortly after injury, in which necrotic cells are accom-
panied by replicating cells lining the injured proximal
tubule. The commitment to DNA synthesis is rapid and
temporally coincides with the emergence of the morpho-
logic and functional derangements. Data to be presented
will support the hypothesis that renal injury and recovery
are part of the same responses and that these processes
depend on proper coordination of the cell cycle machin-
ery. It will also be shown that the engagement of the cell
cycle not only underlies recovery but is an important de-
terminant of whether cells survive the injury itself.
CELL CYCLE PROGRESSION AND
ITS REGULATION
Studies with eukaryotic models have elucidated that
orderly progression through the cell cycle is regulated by
the sequential synthesis, activation, compartmentaliza-
tion, and degradation of proteins controlling both entry
and exit from each phase of the cycle: G1 (gap-1), S (DNA
synthesis), G2 (gap-2), and M (mitosis) (Fig. 1). One of the
major controls on cell cycle progression is the regulation
of phosphorylation of different substrates by interacting
proteins consisting of a cyclin and a cyclin-dependent ki-
nase (cdk). Cyclins, the regulatory subunit of the het-
erodimer, were originally found by nature of their cyclic
oscillations during the sea urchin cell cycle [1]. The first
